Dr Khanh B Tran

PhD, MD (Summa Cum Laude)


2018: University of Auckland Partnership Appeal Award

2018: University of Auckland Doctoral Scholarship 

2018: New Zealand Society for Oncology Travel Award: NZSO 50th Anniversary 2018 Conference 

2017: European Society for Medical Oncology/New Zealand Society for Oncology Travel Award: ESMO Asia Congress, Singapore 2017.

2016: Best Poster Prize - Cancer Biology Meeting, Queenstown Molecular Biology 2018 Conference

2016: Certificate of Recognition - European Association for Cancer Research

2016: European Society for Medical Oncology/New Zealand Society for Oncology Travel Award: ESMO Asia Congress, Singapore 2016.

2015: New Zealand Cancer Society Doctoral Scholarship

Areas of expertise

Clinical hematology-oncology

Signal transduction in cancer

Selective inhibitors of phosphoinositide 3-Kinases (PI3Ks) 

BRAF- and RAS-mutant melanoma

Targeted therapies in cancer treatment

Drug combination

Cytokines in tumor microenvironment  

CRISPR/Cas9 screens

Bead-based multiplexing immunoassays


Burden of Cancers and Diseases

Selected publications and creative works (Research Outputs)

  • Tran, K. B., Buchanan, C. M., & Shepherd, P. R. (2020). Evolution of Molecular Targets in Melanoma Treatment. Current pharmaceutical design, 26 (4), 396-414. 10.2174/1381612826666200130091318
    Other University of Auckland co-authors: Christina Buchanan
  • GBD 2017 Colorectal Cancer Collaborators, & Tran, K. B. (2019). The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet Gastroenterology & Hepatology, 4 (12), 913-933. 10.1016/S2468-1253(19)30345-0
    URL: http://hdl.handle.net/2292/48967
  • Global Burden of Disease Cancer Collaboration, & Tran, B. K. (2019). Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncology, online first10.1001/jamaoncol.2019.2996
    URL: http://hdl.handle.net/2292/48669
  • Britto, D. D., Wyroba, B., Chen, W., Lockwood, R. A., Tran, K. B., Shepherd, P. R., ... Astin, J. W. (2018). Macrophages enhance Vegfa-driven angiogenesis in an embryonic zebrafish tumour xenograft model. DMM Disease Models and Mechanisms, 11 (12).10.1242/dmm.035998
    URL: http://hdl.handle.net/2292/46170
    Other University of Auckland co-authors: Jonathan Astin, Christopher Hall, Wenxuan Chen
  • Tran, B. K., & Shepherd, P. R. (2018). New combination therapies for melanoma. Paper presented at Maurice Wilkins Centre Research Symposium, Auckland, New Zealand. 6 September - 7 September 2018.
    URL: http://hdl.handle.net/2292/46728
  • Tran, B. K., Shih, J. H., Wang, Q., Jamieson, S., Print, C. G., Tsai, P. S., ... Buchanan, C. M. (2018). Co-targeting BRAF and VEGF-A receptors synergistically inhibited the growth of BRAF-mutant and BRAF wild-type melanomas. Paper presented at New Zealand Society for Oncology Conference, Queenstown, New Zealand. 24 August - 25 August 2018.
    Other University of Auckland co-authors: Betty Jen-Hsing Shih, Claire Wang, Stephen Jamieson, Cristin Print, Peter Tsai, Cherie Blenkiron, Christina Buchanan
  • Tran, B., Hunter, F., Jamieson, S., Kolekar, S., Li, D., Kakadiya, P., ... Bohlander, S. K. (2017). Preclinical efficacy and sensitivity determinants of statins in molecularly-defined models of melanoma. Paper presented at New Zealand Society for Oncology Conference, Auckland, New Zealand.
    Other University of Auckland co-authors: Francis Hunter, Stephen Jamieson, Purvi Kakadiya, Cristin Print, Stefan Bohlander, Peter Shepherd


Contact details

Primary office location

M&HS BUILDING 504 - Bldg 504
Level 2, Room 205
New Zealand

Web links